Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
UBS
US Department of Justice
McKesson
Citi
Healthtrust
McKinsey
Boehringer Ingelheim
Johnson and Johnson

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021958

« Back to Dashboard

NDA 021958 describes LAMISIL AT, which is a drug marketed by Glaxosmithkline Cons and is included in two NDAs. It is available from three suppliers. Additional details are available on the LAMISIL AT profile page.

The generic ingredient in LAMISIL AT is terbinafine hydrochloride. There are twenty-seven drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the terbinafine hydrochloride profile page.
Summary for 021958
Tradename:LAMISIL AT
Applicant:Glaxosmithkline Cons
Ingredient:terbinafine
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021958
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LAMISIL AT terbinafine GEL;TOPICAL 021958 NDA Novartis Consumer Health, Inc. 0067-6239 N 0067-6239-21
LAMISIL AT terbinafine GEL;TOPICAL 021958 NDA Novartis Consumer Health, Inc. 0067-6239 N 0067-6239-42

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:GEL;TOPICALStrength1%
Approval Date:Jul 24, 2006TE:RLD:Yes

Expired US Patents for NDA 021958

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Cons LAMISIL AT terbinafine GEL;TOPICAL 021958-001 Jul 24, 2006 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Cons LAMISIL AT terbinafine GEL;TOPICAL 021958-001 Jul 24, 2006 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Cons LAMISIL AT terbinafine GEL;TOPICAL 021958-001 Jul 24, 2006 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKesson
Merck
Baxter
UBS
Chubb
Medtronic
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.